Bioqual Inc BIOQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BIOQ is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $80.00
- Day Range
- $75.00–77.00
- 52-Week Range
- $59.00–82.00
- Bid/Ask
- $53.00 / $200.00
- Market Cap
- $67.08 Mil
- Volume/Avg
- 686 / 383
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.67%
- Dividend Yield (Forward)
- 0.67%
- Total Yield
- 0.67%
Company Profile
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 117
- Website
- https://www.bioqual.com
Valuation
|
Metric
|
BIOQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.74 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
BIOQ
Financial Strength
|
Metric
|
BIOQ
|
|---|---|
Quick Ratio | 3.75 |
Current Ratio | 4.14 |
Interest Coverage | 107.19 |
Quick Ratio
BIOQ
Profitability
|
Metric
|
BIOQ
|
|---|---|
Return on Assets (Normalized) | 14.91% |
Return on Equity (Normalized) | 17.85% |
Return on Invested Capital (Normalized) | 17.51% |
Return on Assets
BIOQ
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Mwxxtgmm | Vqps | $209.3 Bil | |
DHR
| Danaher Corp | Qntpqfdkk | Ghhbrgv | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Qjbxpthm | Hlnbrn | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Gsbtfyjtyy | Kvsgs | $41.0 Bil | |
A
| Agilent Technologies Inc | Kyrvbggycb | Kmkwm | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Yxqdczkf | Bfmryn | $26.4 Bil | |
ICLR
| Icon PLC | Qpbkhzym | Cccwnl | $24.8 Bil | |
ILMN
| Illumina Inc | Fkkdvlrjq | Hhvbrt | $19.3 Bil | |
WAT
| Waters Corp | Scbrbtwbw | Fvrwk | $18.3 Bil | |
LH
| Laboratory Corp of America Holdings | Gfhmmgbwv | Jwwkkr | $17.5 Bil |